|
|
||||||||||||||
|
|
|||||||||||||||
REPORT |
Laboratory of Experimental Haematology, Department of Haematology, Leiden University Medical Centre, Leiden, Netherlands
Correspondence to:
Correspondence to:
Dr W E Fibbe, Department of Haematology, Leiden University Medical Centre, Location C2R Room 137, 2333 AA Leiden, Netherlands;
W.E.Fibbe@LUMC.nl
Keywords: mesenchymal stem cells; skeletal repair
Abbreviations: MSC, mesenchymal stem cell; CFU-F, colony forming unit fibroblastic
| The first 150 words of the full text of this article appear below. |
The bone marrow serves as a reservoir for different classes of stem cells. In addtion to haematopoietic stem cells the bone marrow comprises a population of marrow stromal cells or mesenchymal stem cells (MSCs). Stromal cells exhibit multilineage differentiation capacity, and are able to generate progenitors with restricted developmental potential, including fibroblasts, osteoblasts, adipocytes, and chondrocyte progenitors.13
Recently, techniques have become available to isolate and grow mesenchymal progenitors and to manipulate their growth under defined in vitro culture conditions. As a result MSCs can be rapidly expanded to numbers that are required for clinical application. Here the role of MSCs for repair of bone and cartilage is discussed.
MARROW STROMAL CELLS
Marrow stromal cells comprise a heterogenous population of cells, including reticular endothelial cells, fibroblasts, adipocytes, and osteogenic precursor cells that provide growth factors, cell to cell interactions, and matrix proteins that play a part in the regulation of haematopoiesis.46 The notion that
This article has been cited by other articles:
![]() |
R. Abdi, P. Fiorina, C. N. Adra, M. Atkinson, and M. H. Sayegh Immunomodulation by Mesenchymal Stem Cells: A Potential Therapeutic Strategy for Type 1 Diabetes Diabetes, July 1, 2008; 57(7): 1759 - 1767. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Dekel, E. Shezen, S. Even-Tov-Friedman, H. Katchman, R. Margalit, A. Nagler, and Y. Reisner Transplantation of Human Hematopoietic Stem Cells into Ischemic and Growing Kidneys Suggests a Role in Vasculogenesis but Not Tubulogenesis Stem Cells, May 1, 2006; 24(5): 1185 - 1193. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Kafienah, S. Mistry, C. Williams, and A. P. Hollander Nucleostemin Is a Marker of Proliferating Stromal Stem Cells in Adult Human Bone Marrow Stem Cells, April 1, 2006; 24(4): 1113 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Liu, D. M. Kemeny, B. C. Heng, H. W. Ouyang, A. J. Melendez, and T. Cao The immunogenicity and immunomodulatory function of osteogenic cells differentiated from mesenchymal stem cells. J. Immunol., March 1, 2006; 176(5): 2864 - 2871. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yokota, Y. Kawakami, Y. Nagai, J.-x. Ma, J.-Y. Tsai, P. W. Kincade, and S. Sato Bone Marrow Lacks a Transplantable Progenitor for Smooth Muscle Type {alpha}-Actin-Expressing Cells Stem Cells, January 1, 2006; 24(1): 13 - 22. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |